Baicalin attenuates high fat diet-induced obesity and liver dysfunction: Dose-response and potential role of CaMKKβ/AMPK/ACC pathway

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2349-2359

  Xi, Youli ^a   Wu, Miaozong ^b   Li, Hongxia ^a   Dong, Siqi ^a   Luo, Erfei ^a   Gu, Mingbo ^a   Shen, Xiao ^a   Jiang, Yabo ^a   Liu, Yaqun ^a   Liu, Hua ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b MARSHALL UNIVERSITY   (United States)

Author keywords

Acetyl CoA carboxylase; AMP activated protein kinase; Baicalin; Ca 2+ CaM dependent protein kinase kinase ; Liver dysfunction; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BAICALIN; CAM DEPENDENT PROTEIN KINASE KINASE BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; FLAVONOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FATTY LIVER; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID DIET; LIPOGENESIS; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DRUG EFFECTS; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE; ALANINE TRANSAMINASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; DIET, HIGH-FAT; FATTY LIVER; FLAVONOIDS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84928136552     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374037     Document Type: Article

References (35)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, AmmarW, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov W, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the global burden of disease study 2013. Lancet 2014;384:766-781.
2. Swinburn B, Sacks G, Ravussin E: Increased food energy supply is more than sufficient to explain the us epidemic of obesity. Am J Clin Nutr 2009;90:1453-1456.
3. Boren J, Taskinen MR, Olofsson SO, Levin M: Ectopic lipid storage and insulin resistance: A harmful relationship. J Intern Med. 2013;274:25-40.
4. Perry RJ, Samuel VT, Petersen KF, Shulman GI: The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014;510:84-91.
5. Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ: Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 2014;146:726-735.
6. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ: Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-1351.
7. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM: Prevalence of nonalcoholic fatty liver disease in the united states: The third national health and nutrition examination survey 1988-1994. Am J Epidemiol 2013;178:38-45.
8. Zhang XW, Li WF, Li WW, Ren KH, Fan CM, Chen YY, Shen YL: Protective effects of the aqueous extract of scutellaria baicalensis against acrolein-induced oxidative stress in cultured human umbilical vein endothelial cells. Pharmaceutical biology 2011;49:256-261.
9. Song KH, Lee SH, Kim BY, Park AY, Kim JY: Extracts of Scutellaria baicalensis reduced body weight and blood triglyceride in db/db mice. Phytother Res 2013;27:244-250.
10. Huang WH, Lee AR, Yang CH: Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis georgi. Bioscience, biotechnology and biochemistry 2006;70:2371-2380.
11. Waisundara VY, Hsu A, Huang D, Tan BK: Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic wistar rats. Am J Chin Med 2008;36:517-540.
12. Regulska-Ilow B, Biernat J, Grajeta H, How R, Drzewicka M: Influence of bioflavonoids from the radix extract of scutellaria baicalensis on the level of serum lipids, and the development of laboratory rats fed with fresh and oxidized fats. Nahrung 2004;48:123-128.
13. Sekiya N, Kogure T, Kita T, Kasahara Y, Sakakibara I, Goto H, Shibahara N, Shimada Y, Terasawa K: Reduction of plasma triglyceride level and enhancement of plasma albumin concentration by oren-gedoku-to administration. Phytomedicine 2002;9:455-460.
14. Sekiya N, Kainuma M, Hikiami H, Nakagawa T, Kouta K, Shibahara N, Shimada Y, Terasawa K: Oren-gedoku-to and keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits. Biol Pharm Bull 2005;28:294-298.
15. Fujimoto M, Tsuneyama K, Kainuma M, Sekiya N, Goto H, Takano Y, Terasawa K, Selmi C, Gershwin ME, Shimada Y: Evidence-based efficacy of kampo formulas in a model of non alcoholic fatty liver. Exp Biol Med (Maywood) 2008;233:328-337.
16. Li HB, Chen F: Isolation and purification of baicalein, wogonin and oroxylin a from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr A 2005; 1074:107110.
17. Guo HX, Liu DH, Ma Y, Liu JF, Wang Y Du ZY, Wang X, Shen JK, Peng HL: Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacol Sin 2009;30:1505-1512.
18. Lee H, Kang R, Hahn Y Yang Y Kim SS, Cho SH, Chung SI, Yoon Y: Antiobesity effect of baicalin involves the modulations of proadipogenic and antiadipogenic regulators of the adipogenesis pathway. Phytother Res 2009;23:1615-1623.
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
20. Liu H, Blough ER, Arvapalli R, Wang Y, Reiser PJ, Paturi S, Katta A, Harris R, Nepal N,WuM: Regulation of contractile proteins and protein translational signaling in disused muscle. Cell Physiol Biochem 2012;30:1202-1214.
21. Min W, Liu X, Qian Q, Lin B, Wu D, Wang M, Ahmad I, Yusuf N, Luo D: The effects of baicalin against uva-induced photoaging in skin fibroblasts. Am J Chin Med 2014;42:709-727.
22. Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F: Baicalin attenuates inflammation by inhibiting nf-kappab activation in cigarette smoke induced inflammatory models. Pulm Pharmacol Ther 2010;23:411-419.
23. Zhu J, Wang J, Sheng Y, Zou Y, Bo L, Wang F, Lou J, Fan X, Bao R, Wu Y, Chen F, Deng X, Li J: Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 2012;7:e35523.
24. Wang C, Blough ER, Arvapalli R, Dai X, Paturi S, Manne N, Addagarla H, Triest WE, Olajide 0,WuM: Metabolic syndrome-induced tubulointerstitial injury: Role of oxidative stress and preventive effects of acetaminophen. Free Radic Biol Med 2013;65:1417-1426.
25. Hulsmans M, Geeraert B, De Keyzer D, Mertens A, Lannoo M, Vanaudenaerde B, Hoylaerts M, Benhabiles N, Tsatsanis C, Mathieu C, Holvoet P: Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. PLoS One 2012;7:e30414.
26. Lindholm CR, Ertel RL, Bauwens JD, Schmuck EG, Mulligan JD, Saupe KW: A high-fat diet decreases ampk activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats. J Physiol Biochem 2013;69:165-175.
27. Li X, Choi Y, Yanakawa Y, Park T: Piperonal prevents high-fat diet-induced hepatic steatosis and insulin resistance in mice via activation of adiponectin/ampk pathway. Int J Obes (Lond) 2014;38:140-147.
28. Toth PP: Cardiology patient page. The "good cholesterol": High-density lipoprotein. Circulation 2005;111:e89-91.
29. Wang C, Nie H, Li K, Zhang YX, Shu KG, ChenXJ: [protective effect of baicalin solid dispersion on d-galactosamine induced acute hepatic injury in mice]. Zhongguo ZhongXi Yi Jie He Za Zhi 2014;34:71-74.
30. Zhang Y, Huang Y, Deng X, Xu Y, Gao Z, Li H: Iron overload-induced rat liver injury: Involvement of protein tyrosine nitration and the effect of baicalin. Eur J Pharmacol 2012;680:95-101.
31. Tong L: Acetyl-coenzyme a carboxylase: Crucial metabolic enzyme and attractive target for drug discovery Cell Mol Life Sci 2005;62:1784-1803.
32. Ha J, Daniel S, Broyles SS, Kim KH: Critical phosphorylation sites for acetyl-coa carboxylase activity. J Biol Chem 1994;269:22162-22168.
33. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, Winder WW: Phosphorylation-activity relationships of ampk and acetyl-coa carboxylase in muscle. J Appl Physiol 2002;92:2475-2482.
34. Green MF, Anderson KA, Means AR: Characterization of the camkkbeta-ampk signaling complex. Cell Signal 2011;23:2005-2012.
35. Ma Y, Yang F, Wang Y, Du Z, Liu D, Guo H, Shen J, Peng H: Camkkbeta is involved in amp-activated protein kinase activation by baicalin in lkbl deficient cell lines. PLoS ONE 2012;7:e47900.